JP2012502071A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502071A5 JP2012502071A5 JP2011526411A JP2011526411A JP2012502071A5 JP 2012502071 A5 JP2012502071 A5 JP 2012502071A5 JP 2011526411 A JP2011526411 A JP 2011526411A JP 2011526411 A JP2011526411 A JP 2011526411A JP 2012502071 A5 JP2012502071 A5 JP 2012502071A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formulated
- composition according
- peptide
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 238000001990 intravenous administration Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000011505 plaster Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08016142.5 | 2008-09-12 | ||
| EP08016142A EP2163259B1 (en) | 2008-09-12 | 2008-09-12 | Use of an Ang-(1-7) receptor agonist in acute lung injury |
| PCT/EP2009/006619 WO2010028845A2 (en) | 2008-09-12 | 2009-09-11 | Use of an ang-(1-7) receptor agonist in acute lung injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257932A Division JP5881122B2 (ja) | 2008-09-12 | 2013-12-13 | 急性肺損傷におけるａｎｇ−（１−７）レセプターアゴニストの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012502071A JP2012502071A (ja) | 2012-01-26 |
| JP2012502071A5 true JP2012502071A5 (enExample) | 2013-05-16 |
Family
ID=40430691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526411A Pending JP2012502071A (ja) | 2008-09-12 | 2009-09-11 | 急性肺損傷におけるａｎｇ−（１−７）レセプターアゴニストの使用 |
| JP2013257932A Expired - Fee Related JP5881122B2 (ja) | 2008-09-12 | 2013-12-13 | 急性肺損傷におけるａｎｇ−（１−７）レセプターアゴニストの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257932A Expired - Fee Related JP5881122B2 (ja) | 2008-09-12 | 2013-12-13 | 急性肺損傷におけるａｎｇ−（１−７）レセプターアゴニストの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20110281805A1 (enExample) |
| EP (2) | EP2163259B1 (enExample) |
| JP (2) | JP2012502071A (enExample) |
| KR (1) | KR20110074978A (enExample) |
| CN (2) | CN102164614B (enExample) |
| BR (2) | BR122013002187A2 (enExample) |
| CA (1) | CA2736922C (enExample) |
| ES (1) | ES2393455T3 (enExample) |
| WO (1) | WO2010028845A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2163259B1 (en) * | 2008-09-12 | 2012-06-13 | Charité-Universitätsmedizin Berlin (Charité) | Use of an Ang-(1-7) receptor agonist in acute lung injury |
| CN104302305A (zh) * | 2011-12-16 | 2015-01-21 | 塔瑞克斯制药有限公司 | 用于治疗纤维化的血管紧张素 |
| CN102532265A (zh) * | 2011-12-29 | 2012-07-04 | 中国人民解放军第四军医大学 | 一种短肽、其异构体及其应用 |
| CA2863699A1 (en) * | 2012-02-10 | 2013-08-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of peripheral vascular disease |
| US8557958B1 (en) | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| AU2013315004A1 (en) * | 2012-09-17 | 2015-04-02 | Tarix Pharmaceuticals Ltd. | Oral formulations of angiotensin |
| US8633158B1 (en) * | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| WO2014189634A1 (en) * | 2013-04-19 | 2014-11-27 | University Of Iowa Research Foundation | Angiotensins in muscular dystrophy |
| EP3003345A4 (en) | 2013-05-24 | 2017-03-01 | Tarix Pharmaceuticals Ltd. | Angiotensin peptides in treating marfan syndrome and related disorders |
| WO2015054005A1 (en) * | 2013-10-11 | 2015-04-16 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of bdnf-related conditions |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| KR20170026368A (ko) * | 2014-07-17 | 2017-03-08 | 유니버시티 오브 써던 캘리포니아 | 근골격 질환들의 치료를 위한 방법들, 화합물들 및 조성물들 |
| US10183055B2 (en) | 2014-07-21 | 2019-01-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications |
| WO2016014342A2 (en) | 2014-07-21 | 2016-01-28 | Arizona Board Of Regents For The University Of Arizona | Ang-(1-7) derviative oligopeptides and methods for using and producing the same |
| EP3281133A1 (en) * | 2015-04-08 | 2018-02-14 | Koninklijke Philips N.V. | Tool for recommendation of ventilation therapy guided by risk score for acute respirator distress syndrome (ards) |
| WO2018129511A2 (en) * | 2017-01-09 | 2018-07-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) and derivative oligopeptides for the treatment of traumatic brain injury and other cognitive impairments |
| US20200188473A1 (en) * | 2017-05-02 | 2020-06-18 | Beth Israel Deaconess Medical Center, Inc. | Combination therapy for cancer |
| CN112316107B (zh) * | 2019-07-17 | 2023-01-06 | 首都医科大学附属北京妇产医院 | 血管紧张素(1-7)在胰腺疾病中的应用 |
| EP4117703A1 (en) * | 2020-03-13 | 2023-01-18 | Constant Therapeutics LLC | Methods and compositions for treatment of coronavirus infection |
| WO2022094025A1 (en) * | 2020-10-30 | 2022-05-05 | Gere Dizerega | Angiotensin-1-7 for the treatment of covid-19 |
| MX2023008832A (es) | 2021-01-28 | 2023-10-23 | Capacity Bio Inc | Métodos y agentes que estimulan el recambio mitocondrial para el tratamiento de enfermedades. |
| EP4085921A1 (en) | 2021-05-04 | 2022-11-09 | CU-Pharmaceuticals UG | Angiotensin-(1-7) in the treatment of sars-cov related diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110895A (en) * | 1996-12-16 | 2000-08-29 | University Of Southern California | Method of promoting healing in skin grafts |
| YU78601A (sh) | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| EP1485116A4 (en) * | 2002-02-27 | 2006-06-07 | Univ Wake Forest | ANGIOTENSIN- (1-7) AND AGONISTS OF ANGIOTENSIN- (1-7) FOR THE INHIBITION OF GROWTH OF CANCER CELLS |
| US20050119180A1 (en) * | 2002-03-28 | 2005-06-02 | Roks Antonius J.M. | Use of angiotensin 1-7 for enhancing cardiac function |
| EP1723962A1 (en) * | 2005-05-19 | 2006-11-22 | IMBA-Institut für Molekulare Biotechnologie GmbH | Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries |
| BRPI0503122A (pt) | 2005-05-30 | 2007-05-02 | Univ Minas Gerais | composições farmacêuticas do peptìdeo angiotensina-(1-7) [ang-(1-7)] e seus análogos, agonistas e antagonistas usando as ciclodextrinas, seus derivados, e o polìmeros biodegradáveis e/ou dos produtos derivados para uso no controle das funções do sistema reprodutivo |
| BRPI0502497A (pt) | 2005-06-28 | 2007-02-06 | Univ Minas Gerais | uso de agonistas e antagonistas do receptor acoplado a proteìna g, mas, como moduladores de atividade apoptótica para o estudo, a prevenção e o tratamento de doenças |
| BRPI0602366B1 (pt) | 2006-04-26 | 2017-12-12 | Universidade Federal De Minas Gerais | Use of agonists of the receptor coupled to protein g, but, in the treatment of metabolic syndrome, its components and their complications |
| WO2008130217A1 (en) * | 2006-08-08 | 2008-10-30 | Applied Nanosystems B.V. | Cyclic angiotensin analogs |
| EP2163259B1 (en) * | 2008-09-12 | 2012-06-13 | Charité-Universitätsmedizin Berlin (Charité) | Use of an Ang-(1-7) receptor agonist in acute lung injury |
-
2008
- 2008-09-12 EP EP08016142A patent/EP2163259B1/en not_active Not-in-force
- 2008-09-12 ES ES08016142T patent/ES2393455T3/es active Active
-
2009
- 2009-09-11 CA CA2736922A patent/CA2736922C/en not_active Expired - Fee Related
- 2009-09-11 JP JP2011526411A patent/JP2012502071A/ja active Pending
- 2009-09-11 BR BR122013002187A patent/BR122013002187A2/pt not_active IP Right Cessation
- 2009-09-11 WO PCT/EP2009/006619 patent/WO2010028845A2/en not_active Ceased
- 2009-09-11 BR BRPI0918443A patent/BRPI0918443A2/pt not_active IP Right Cessation
- 2009-09-11 US US13/063,685 patent/US20110281805A1/en not_active Abandoned
- 2009-09-11 KR KR1020117008209A patent/KR20110074978A/ko not_active Ceased
- 2009-09-11 CN CN200980135629.4A patent/CN102164614B/zh not_active Expired - Fee Related
- 2009-09-11 CN CN2013101168734A patent/CN103263661A/zh active Pending
- 2009-09-11 EP EP09778494A patent/EP2341938A2/en not_active Ceased
-
2012
- 2012-08-21 US US13/590,894 patent/US8383772B2/en not_active Expired - Fee Related
-
2013
- 2013-06-28 US US13/931,168 patent/US20140073760A1/en not_active Abandoned
- 2013-12-13 JP JP2013257932A patent/JP5881122B2/ja not_active Expired - Fee Related
-
2015
- 2015-06-25 US US14/750,500 patent/US20160051621A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502071A5 (enExample) | ||
| MX2010001839A (es) | Metodo y aparato para comunicacion y metodo y aparato para controlar comunicacion. | |
| WO2011080102A3 (en) | Glp-1 analogues and derivatives | |
| JP2015518885A5 (enExample) | ||
| JP2009102342A5 (enExample) | ||
| WO2009006095A3 (en) | Dual portion lozenge dosage form | |
| JP2010504343A5 (enExample) | ||
| JP2013541523A5 (enExample) | ||
| AR075148A1 (es) | Formulacion de rasagilina de liberacion retardada. proceso para fabricar citrato de rasagilina | |
| WO2010103544A3 (en) | A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants | |
| JP2009535352A5 (enExample) | ||
| JP2008533007A5 (enExample) | ||
| MY155402A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| WO2008069917A3 (en) | Novel cyclic peptides | |
| WO2015073491A1 (en) | Formulations of azaindole compounds | |
| JP2013542247A5 (enExample) | ||
| JP2010521417A5 (enExample) | ||
| NZ597858A (en) | Vaccines and compositions against streptococcus pneumoniae | |
| JP2010536889A5 (enExample) | ||
| NZ597488A (en) | Pharmaceutical for oral delivery comprising mgbg and methods of treating disease | |
| RU2009122241A (ru) | Твердые формы рацемического илапразола | |
| NZ600583A (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
| WO2010082220A3 (en) | Sustained release pharmaceutical composition of quetiapine and process for preparation thereof | |
| WO2012020301A3 (en) | Oral controlled release pharmaceutical compositions of blonanserin | |
| JP2011528897A5 (enExample) |